KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, while Mizuho Financial Group is set to acquire KKR-backed Avendus Capital, valuing the homegrown investment bank at Rs 6,000 crore ($700 million), The Economic Times reported on Monday.
KKR-backed IVI to buy ART Fertility Clinics for up to $450m
KKR-backed IVI RMA Global, a US-based leader in infertility treatment, is set to acquire ART Fertility Clinics for $400-450 million, The Economic Times reported on Monday (June 9), citing people familiar with the matter.
The acquisition will aid IVI RMA’s global expansion plans by adding India to its footprint that currently spans over 15 countries and over 190 clinical offices across the US, Europe and Latin America.
Both parties are in the final stages of documentation for a shareholders’ agreement and are hoping to wrap up the transaction by June-end, the report said.
Mizuho to buy Avendus from KKR at $700m valuation
Mizuho Financial Group is set to acquire KKR-backed Avendus Capital, valuing the homegrown investment bank at Rs 6,000 crore ($700 million), The Economic Times reported on Monday.
Mizuho and KKR, along with the senior leadership of Avendus, agreed on final deal terms in the last few days, even as private equity group Caryle, the only other serious contender in the fray, was circling the prospect, the report said.
Mizuho Group CEO Masahiro Kihara is scheduled to visit the country later this week for official engagements and a formal announcement is due at that time.
